|
1
|
Srinivasan S, Ranga RS, Burikhanov R, Han
SS and Chendil D: Par-4-dependent apoptosis by the dietary compound
withaferin A in prostate cancer cells. Cancer Res. 67:246–253.
2007. View Article : Google Scholar
|
|
2
|
Malik F, Kumar A, Bhushan S, et al:
Reactive oxygen species generation and mitochondrial dysfunction in
the apoptotic cell death of human myeloid leukemia HL-60 cells by a
dietary compound withaferin A with concomitant protection by
N-acetyl cysteine. Apoptosis. 12:2115–2133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stan SD, Hahm ER, Warin R and Singh SV:
Withaferin A causes FOXO3a- and Bim-dependent apoptosis and
inhibits growth of human breast cancer cells in vivo. Cancer Res.
68:7661–7669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi MJ, Park EJ, Min KJ, Park JW and Kwon
TK: Endoplasmic reticulum stress mediates withaferin A-induced
apoptosis in human renal carcinoma cells. Toxicol In Vitro.
25:692–698. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mayola E, Gallerne C, Esposti DD, et al:
Withaferin A induces apoptosis in human melanoma cells through
generation of reactive oxygen species and down-regulation of Bcl-2.
Apoptosis. 16:1014–1027. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hahm ER, Moura MB, Kelley EE, Van Houten
B, Shiva S and Singh SV: Withaferin A-induced apoptosis in human
breast cancer cells is mediated by reactive oxygen species. PLoS
One. 6:e233542011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mandal C, Dutta A, Mallick A, Chandra S,
Misra L and Sangwan RS: Withaferin A induces apoptosis by
activating p38 Mitogen-activated protein kinase signaling cascade
in leukemic cells of lymphoid and myeloid origin through
mitochondrial death cascade. Apoptosis. 13:1450–1464. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oh JH, Lee TJ, Kim SH, et al: Induction of
apoptosis by withaferin A in human leukemia U937 cells through
down-regulation of Akt phosphorylation. Apoptosis. 13:1494–1504.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Samadi AK, Tong X, Mukerji R, Zhang H,
Timmermann BN and Cohen MS: Withaferin A, a cytotoxic steroid from
Vassobia breviflora, induces apoptosis in human head and neck
squamous cell carcinoma. J Nat Prod. 73:1476–1481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tanabe T and Tohnai N: Cyclooxygenase
isozymes and their gene structures and expression. Prostaglandins
Other Lipid Mediat. 68–69:95–114. 2002. View Article : Google Scholar
|
|
11
|
Tsuji S, Tsujii M, Kawano S and Hori M:
Cyclooxygenase-2 upregulation as a perigenetic change in
carcinogenesis. J Exp Clin Cancer Res. 20:117–129. 2001.PubMed/NCBI
|
|
12
|
Ledwith BJ, Pauley CJ, Wagner LK, Rokos
CL, Alberts DW and Manam S: Induction of cyclooxygenase-2
expression by peroxisome proliferators and non-tetradecanoylphorbol
12,13-myristate-type tumor promoters in immortalized mouse liver
cells. J Biol Chem. 272:3707–3714. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okami J, Yamamoto H, Fujiwara Y, et al:
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Clin Cancer Res. 5:2018–2024. 1999.PubMed/NCBI
|
|
14
|
Eberhart CE, Coffey RJ, Radhika A,
Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of
cyclooxygenase 2 gene expression in human colorectal adenomas and
adenocarcinomas. Gastroenterology. 107:1183–1188. 1994.PubMed/NCBI
|
|
15
|
Ryu HS, Chang KH, Yang HW, Kim MS, Kwon HC
and Oh KS: High cyclooxygenase-2 expression in stage IB cervical
cancer with lymph node metastasis or parametrial invasion. Gynecol
Oncol. 76:320–325. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hara S, Kondo Y, Matsuzawa I, et al:
Expression of cycloxygenase-2 in human bladder and renal cell
carcinoma. Adv Exp Med Biol. 507:123–126. 2002. View Article : Google Scholar
|
|
17
|
Celenk F, Bayramoglu I, Yilmaz A, Menevse
A and Bayazit Y: Expression of cyclooxygenase-2, 12-lipoxygenase,
and inducible nitric oxide synthase in head and neck squamous cell
carcinoma. J Craniofac Surg. 24:1114–1117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hara A, Yoshimi N, Niwa M, Ino N and Mori
H: Apoptosis induced by NS-398, a selective cyclooxygenase-2
inhibitor, in human colorectal cancer cell lines. Jpn J Cancer Res.
88:600–604. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sawaoka H, Kawano S, Tsuji S, et al:
Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer
xenografts via induction of apoptosis in nude mice. Am J Physiol.
274:G1061–1067. 1998.PubMed/NCBI
|
|
20
|
Limami Y, Pinon A, Leger DY, et al: HT-29
colorectal cancer cells undergoing apoptosis overexpress COX-2 to
delay ursolic acid-induced cell death. Biochimie. 93:749–757. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang MS, Ji KA, Jeon SB, et al:
Interleukin-13 enhances cyclooxygenase-2 expression in activated
rat brain microglia: implications for death of activated microglia.
J Immunol. 177:1323–1329. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
LeBel CP, Ischiropoulos H and Bondy SC:
Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of
reactive oxygen species formation and oxidative stress. Chem Res
Toxicol. 5:227–231. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Um HJ, Min KJ, Kim DE and Kwon TK:
Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of
human renal carcinoma Caki cells. Biochem Biophys Res Commun.
427:24–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu B, Qu L and Tao H: Cyclo-oxygenase 2
up-regulates the effect of multidrug resistance. Cell Biol Int.
34:21–25. 2009.PubMed/NCBI
|
|
25
|
Hsu AL, Ching TT, Wang DS, Song X,
Rangnekar VM and Chen CS: The cyclooxygenase-2 inhibitor celecoxib
induces apoptosis by blocking Akt activation in human prostate
cancer cells independently of Bcl-2. J Biol Chem. 275:11397–11403.
2000. View Article : Google Scholar
|
|
26
|
Suttana W, Mankhetkorn S, Poompimon W, et
al: Differential chemosensitization of P-glycoprotein
overexpressing K562/Adr cells by withaferin A and Siamois
polyphenols. Mol Cancer. 9:992010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaileh M, Vanden Berghe W, Heyerick A, et
al: Withaferin A strongly elicits IkappaB kinase beta
hyperphosphorylation concomitant with potent inhibition of its
kinase activity. J Biol Chem. 282:4253–4264. 2007. View Article : Google Scholar
|
|
28
|
Arico S, Pattingre S, Bauvy C, et al:
Celecoxib induces apoptosis by inhibiting
3-phosphoinositide-dependent protein kinase-1 activity in the human
colon cancer HT-29 cell line. J Biol Chem. 277:27613–27621. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu GS, Zou SQ, Liu ZR, Tang ZH and Wang
JH: Celecoxib inhibits proliferation and induces apoptosis via
prostaglandin E2 pathway in human cholangiocarcinoma cell lines.
World J Gastroenterol. 9:1302–1306. 2003.PubMed/NCBI
|
|
30
|
Wu G, Yi J, Di F, Zou S and Li X:
Celecoxib inhibits proliferation and induces apoptosis via
cyclooxygenase-2 pathway in human pancreatic carcinoma cells. J
Huazhong Univ Sci Technolog Med Sci. 25:42–44. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Y, Tang XM, Half E, Kuo MT and
Sinicrope FA: Cyclooxygenase-2 overexpression reduces apoptotic
susceptibility by inhibiting the cytochrome c-dependent apoptotic
pathway in human colon cancer cells. Cancer Res. 62:6323–6328.
2002.PubMed/NCBI
|
|
32
|
Xu Z, Choudhary S, Voznesensky O, et al:
Overexpression of COX-2 in human osteosarcoma cells decreases
proliferation and increases apoptosis. Cancer Res. 66:6657–6664.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hashitani S, Urade M, Nishimura N, et al:
Apoptosis induction and enhancement of cytotoxicity of anticancer
drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in
human head and neck carcinoma cell lines. Int J Oncol. 23:665–672.
2003.PubMed/NCBI
|
|
34
|
Cai Y, Sheng ZY, Chen Y and Bai C: Effect
of Withaferin A on A549 cellular proliferation and apoptosis in
non-small cell lung cancer. Asian Pac J Cancer Prev. 15:1711–1714.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mohan R, Hammers HJ, Bargagna-Mohan P, et
al: Withaferin A is a potent inhibitor of angiogenesis.
Angiogenesis. 7:115–122. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thaiparambil JT, Bender L, Ganesh T, et
al: Withaferin A inhibits breast cancer invasion and metastasis at
sub-cytotoxic doses by inducing vimentin disassembly and serine 56
phosphorylation. Int J Cancer. 129:2744–2755. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sen N, Banerjee B, Das BB, et al:
Apoptosis is induced in leishmanial cells by a novel protein kinase
inhibitor withaferin A and is facilitated by apoptotic
topoisomerase I-DNA complex. Cell Death Differ. 14:358–367. 2007.
View Article : Google Scholar
|
|
38
|
Fuska J, Fuskova A, Rosazza JP and
Nicholas AW: Novel cytotoxic and antitumor agents. IV Withaferin A:
relation of its structure to the in vitro cytotoxic effects on P388
cells. Neoplasma. 31:31–36. 1984.
|
